Skip to main content

Vaccines For Cancer Immunotherapy

In Order to Read Online or Download Vaccines For Cancer Immunotherapy Full eBooks in PDF, EPUB, Tuebl and Mobi you need to create a Free account. Get any books you like and read everywhere you want. Fast Download Speed ~ Commercial & Ad Free. We cannot guarantee that every book is in the library!

Vaccines for Cancer Immunotherapy

Vaccines for Cancer Immunotherapy Book
Author : Nima Rezaei,Mahsa Keshavarz-Fathi
Publisher : Academic Press
Release : 2018-10-17
ISBN : 0128140402
Language : En, Es, Fr & De

GET BOOK

Book Description :

Therapeutic cancer vaccines represent a type of active cancer immunotherapy. Clinicians, scientists, and researchers working on cancer treatment require evidence-based and up-to-date resources relating to therapeutic cancer vaccines. Vaccines for Cancer Immunotherapy provides a reference for cancer treatment for clinicians and presents a well-organized resource for determining high-potential research areas. The book considers that this promising modality can be made more feasible as a treatment for cancer. Chapters cover cancer immunology, general approaches to cancer immunotherapy, vaccines, tumor antigens, the strategy of allogeneic and autologous cancer vaccines, personalized vaccines, whole-tumor antigen vaccines, protein and peptide vaccines, dendritic cell vaccines, genetic vaccines, candidate cancers for vaccination, obstacles to developing therapeutic cancer vaccines, combination therapy, future perspectives and concluding remarks on therapeutic cancer vaccines. Introduces the feasible immunotherapeutic vaccines for patients with different types of cancer Presents the status of past and current vaccines for cancer treatment Considers advantages and disadvantages of different therapeutic cancer vaccines Looks at the combination of vaccines and other modalities, including immunotherapeutic and conventional methods Analyzes obstacles to development of therapeutic cancer vaccines Gives a view on future perspectives in the application of therapeutic cancer vaccines

Cancer Vaccines and Tumor Immunity

Cancer Vaccines and Tumor Immunity Book
Author : Rimas Orentas,James W. Hodge,Bryon D. Johnson
Publisher : John Wiley & Sons
Release : 2007-10-26
ISBN : 9780470170106
Language : En, Es, Fr & De

GET BOOK

Book Description :

Cancer Vaccines and Tumor Immunity offers a review of the basic scientific discoveries that have moved forward into clinical trials. Presented in the context of real-world human research and experimentation, these major scientific advances demonstrate how our understanding of immune activation, T-regulatory cells, and autoimmunity will impact cancer vaccine design. The authors also explain how vaccination in the context of bone marrow transplantation will open new avenues for clinical study in the future.

Vaccines Developed for Cancer Immunotherapy

Vaccines Developed for Cancer Immunotherapy Book
Author : Aizong Shen
Publisher :
Release : 2018
ISBN :
Language : En, Es, Fr & De

GET BOOK

Book Description :

Vaccines have been successfully used for prophylaxis of infectious diseases for a long time and in the last decades have inspired researchers to make products with similar immunological mechanisms for cancer immunotherapy, which has been developed rapidly into clinical applications and has shown remarkable therapeutic efficacy, as exemplified by chimeric Ag receptor T cell (CAR-T cell) and immune checkpoint inhibitor-based therapies which can efficiently strengthen the body's immune system to fight against cancer, but they are also expensive. Therefore, encouraged by recent success of cancer immunotherapy, scientists are actively developing the low-cost tumor Ag-based vaccines, which, however, usually exhibit weak immunostimulating effects and, therefore, are often formulated with nanoparticulate carriers to form a vaccine adjuvant-delivery system (VADS), which can not only enhance the efficacy but also mitigate the off-target toxicity associated with conventional anticancer vaccines. These nanoparticulate carrier-based VADSs have demonstrated multiple functions, such as targetedly triggering Ag-presenting cells, reeducating tumor-associated macrophages (TAM) to function as tumor suppressor agent, and eliciting robust cytotoxic T lymphocytes (CTLs) to kill tumor cells. This chapter introduces multifunctional VADS that have been engineered with nanoparticulate carriers, including polymeric-, lipid-, metallic-, and cell-based nanoparticles, and used as an alternative to the existent tools for cancer immunotherapy.

Advancements in Tumor Immunotherapy and Cancer Vaccines

Advancements in Tumor Immunotherapy and Cancer Vaccines Book
Author : Hilal Arnouk
Publisher : BoD – Books on Demand
Release : 2012-02-03
ISBN : 9533079983
Language : En, Es, Fr & De

GET BOOK

Book Description :

Harnessing the potential of the human body's own immune system to attack malignant tumor cells has been the goal of many scientific investigators in recent years, with advances in cancer biology and immunology enabling cancer immunotherapy to become a reality. World-class bench and clinical researchers have joined forces to collaborate and review current developments and trends in cancer immunology for the purposes of this book, and the result is a promising review of contemporary clinical treatments. In each chapter the authors present the scientific basis behind such therapeutic approaches, including cancer vaccines with special focus on prostate cancer, melanoma and novel approaches utilizing both innate and adaptive immune responses.

Tumor Immunology and Immunotherapy

Tumor Immunology and Immunotherapy Book
Author : Robert C. Rees
Publisher : Oxford University Press, USA
Release : 2014-05-20
ISBN : 0199676860
Language : En, Es, Fr & De

GET BOOK

Book Description :

Patients are beginning to benefit from antibody based, cellular and vaccine approaches that are effective against genetically diverse and therapy-resistance cancers. BCG immunotherapy is now being used as a first line treatment for human bladder cancer and the introduction of prophylactic vaccination against Hepatitis B and HPV cancers is starting to show positive results. Following recent FDA approval for a vaccination against prostate cancer, and optimistic results in clinical trials for a vaccine targeting cancer antigens in lung cancer, cancer immunotherapy is now significantly impacting patient clinical management. Tumor Immunology and Immunotherapy provides an up-to-date and comprehensive account of cancer immunity and immunotherapy. It discusses our adaptive and innate immunity to cancer, the mechanisms underpinning our immune response, current approaches to cancer immunotherapy, and how tumour and host responses can circumvent effective anti-cancer immunity. The book examines recent results, publications and current areas of interest including 'immune editing' and the specific issues that are affecting the research and development of vaccines, providing insight into how these problems may be overcome, as viewed by world leaders in the field. Tumor Immunology and Immunotherapy will appeal to clinicians working in oncology and cancer immunotherapy, and research scientists including PhD and masters students, post-doctoral researchers and senior investigators.

General Principles of Tumor Immunotherapy

General Principles of Tumor Immunotherapy Book
Author : Howard L. Kaufman,Jedd D. Wolchok
Publisher : Springer Science & Business Media
Release : 2007-10-22
ISBN : 1402060866
Language : En, Es, Fr & De

GET BOOK

Book Description :

"General Principles of Tumor Immunotherapy: Basic and Clinical Applications of Tumor Immunology" brings together the world’s leading authorities on tumor immunology. This book describes the basic immunology principles that form the foundation of understanding how the immune system recognizes and rejects tumor cells. The role of the innate and adaptive immune responses is discussed and the implications of these responses for the design of clinical strategies to combat cancer are illustrated through both experimental clinical trials and review of current standard of care therapeutic agents. This information will be invaluable to both students of immunology and cancer research and practicing physicians who have patients with cancer. The book provides a comprehensive overview of the field, demonstrates how advances in basic immunology can and are being applied to cancer, and describes the current status of approved immunotherapy regimens.

Novel Approaches and Strategies for Biologics Vaccines and Cancer Therapies

Novel Approaches and Strategies for Biologics  Vaccines and Cancer Therapies Book
Author : Manmohan Singh,Maya Salnikova
Publisher : Academic Press
Release : 2014-12-30
ISBN : 012416661X
Language : En, Es, Fr & De

GET BOOK

Book Description :

Novel Approaches and Strategies for Biologics, Vaccines and Cancer Therapies takes a look at the current strategies, successes and challenges involved with the development of novel formulations of biologics, vaccines and cancer therapy. This thorough reference on the latest trends in the development of diverse modalities will appeal to a broad community of scientists, students and clinicians. Written by leading authors across academia and industry, this book covers important topics such as unique drug delivery devices, non-parenteral delivery trends, novel approaches to the treatment of cancer, immunotherapy and more. It includes real-world cases and examples which highlight formulations with therapeutic proteins, monoclonal antibodies, peptides and biobetters, as well as cases on novel vaccines formulations including evolving pathogens, novel modalities of vaccines, universal vaccines. This book is a thorough and useful resource on the development of novel biologics, vaccines and cancer therapies. Provides strategies for the development of safe and efficacious novel formulations for various modalities of biologics, vaccines and for cancer therapy Highlights novel cases from current clinical trials as well as marketed products Reviews overall successes and challenges in the development of novel formulations, including new molecular targets for the treatment of diseases, design of target-specific therapies, regulatory considerations, individualized therapies

Antigen Presenting Cell Tumour Cell Hybrid Vaccines in Cancer Immunotherapy

Antigen Presenting Cell Tumour Cell Hybrid Vaccines in Cancer Immunotherapy Book
Author : Yehia S. Mohamed
Publisher :
Release : 2017
ISBN :
Language : En, Es, Fr & De

GET BOOK

Book Description :

In recent years, there has been a considerable interest in the development of immunotherapeutic approaches for treating cancers, including strategies for inducing antigen-specific cytotoxic T cells (CTLs) capable of killing tumour cells in situ. These approaches include both the active induction of CTLs by vaccination of tumour bearing patients, and the ex vivo expansion of tumour-specific CTLs for adoptive cellular transfer. One promising approach has been through the generation of hybrid cells, formed by fusion of professional antigen presenting cells (pAPCs) with tumour cells expressing relevant tumour associated antigens. Dendritic cells (DCs) represent the most potent form of pAPCs, and have been widely used in the generation of APC/tumour cell hybrid vaccines, in the context of a range of tumour types. Studies of fusion cell vaccines in animals have demonstrated not only the induction of tumour-specific CTLs, but also protection against subsequent tumour challenge and regression of established tumours. Results of clinical trials in patients have been less dramatic, but have shown the ability of hybrid vaccines to induce tumour-specific T cell responses, in some instances associated with disease stabilization or tumour regression. In addition to dendritic cell fusion vaccines, a number of non-DC fusion vaccines have been described.

Cancer Immunology

Cancer Immunology Book
Author : Nima Rezaei
Publisher : Springer Nature
Release :
ISBN : 3030502872
Language : En, Es, Fr & De

GET BOOK

Book Description :

Cancer Immunology and Immunotherapy

Cancer Immunology and Immunotherapy Book
Author : Glenn Dranoff
Publisher : Springer Science & Business Media
Release : 2011-04-11
ISBN : 9783642141362
Language : En, Es, Fr & De

GET BOOK

Book Description :

The interplay between tumors and their immunologic microenvironment is complex, difficult to decipher, but its understanding is of seminal importance for the development of novel prognostic markers and therapeutic strategies. The present review discusses tumor-immune interactions in several human cancers that illustrate various aspects of this complexity and proposes an integrated scheme of the impact of local immune reactions on clinical outcome. Current active immunotherapy trials have shown durable tumor regressions in a fraction of patients. However, clinical efficacy of current vaccines is limited, possibly because tumors skew the immune system by means of myeloid-derived suppressor cells, inflammatory type 2 T cells and regulatory T cells (Tregs), all of which prevent the generation of effector cells. To improve the clinical efficacy of cancer vaccines in patients with metastatic disease, we need to design novel and improved strategies that can boost adaptive immunity to cancer, help overcome Tregs and allow the breakdown of the immunosuppressive tumor microenvironment.

Cancer Vaccine

Cancer Vaccine Book
Author : Amita Sarkar
Publisher : Discovery Publishing House
Release : 2009
ISBN : 9788183563970
Language : En, Es, Fr & De

GET BOOK

Book Description :

Carbohydrate Based Vaccines and Immunotherapies

Carbohydrate Based Vaccines and Immunotherapies Book
Author : Zhongwu Guo,Geert-Jan Boons
Publisher : John Wiley & Sons
Release : 2009-06-17
ISBN : 0470473274
Language : En, Es, Fr & De

GET BOOK

Book Description :

The fundamental science and the latest developments in carbohydrate-based vaccines The relatively new field of glycoimmunology has emerged from the marriage of glycobiology and immunology, in recognition of the important role carbohydrates play as antigenic determinants. Carbohydrate-Based Vaccines and Immunotherapies comprehensively reviews the state of this exciting field, offering a single source for both the fundamental science and the latest developments. With contributions by leading experts, this resource covers the design, synthesis, evaluation, and applications of various carbohydrate-based vaccines, including polysaccharides, neoglycoproteins, and neoglycolipids. The text approaches vaccine design from a chemical and molecular focus, staying in line with current advances. Key topics covered by Carbohydrate-Based Vaccines and Immunotherapies include: Recent developments towards clinically useful vaccines against bacteria, viruses, parasites, and fungi Using adjuvants to improve immunogenicity and/or immunological properties of vaccines Choosing and designing proper adjuvants for specific targets Abnormal carbohydrates expressed by tumors Carbohydrate-based therapeutic cancer vaccines or cancer immunotherapy Clinical trials results for synthetic cancer vaccines Glycoengineering of cell surface carborhydrates and its anticancer applications Using cell surface carbohydrates for disease diagnosis A single, convenient source of state-of-the-art information from leading authorities in the field, Carbohydrate-Based Vaccines and Immunotherapies is an essential reference for organic chemists and biochemists, academic researchers, and other students and professionals involved in vaccine design.

Cancer Vaccines

Cancer Vaccines Book
Author : Nathan Elliot
Publisher : Nova Publishers
Release : 2006
ISBN : 9781594549687
Language : En, Es, Fr & De

GET BOOK

Book Description :

Cancer vaccines are intended either to treat existing cancers (therapeutic vaccines) or to prevent the development of cancer (prophylactic vaccines). Both types of vaccines have the potential to reduce the burden of cancer. Treatment or therapeutic vaccines are administered to cancer patients and are designed to strengthen the body's natural defences against cancers that have already developed. These types of vaccines may prevent the further growth of existing cancers, prevent the recurrence of treated cancers, or eliminate cancer cells not killed by prior treatments. Prevention or prophylactic vaccines, on the other hand, are administered to healthy individuals and are designed to target cancer-causing viruses and prevent viral infection. This new book presents important and timely research in this dynamic field.

Cancer Vaccines

Cancer Vaccines Book
Author : Adrian Bot,Mihail Obrocea
Publisher : CRC Press
Release : 2019-08-30
ISBN : 9780367387556
Language : En, Es, Fr & De

GET BOOK

Book Description :

Recent advances in immunology and biology have opened new horizons in cancer therapy, included in the expanding array of cancer treatment options, which are immunotherapies, or cancer vaccines, for both solid and blood borne cancers. Cancer Vaccines: Challenges and Opportunities in Translation is the first text in the field to bring immunotherapy treatments from the laboratory trial to the bedside for the practicing oncologist. Cancer Vaccines: Challenges and Opportunities in Translation: Critically analyzes the most promising classes of investigational immunotherapies, integrating their scientific rationale and clinical potential Discusses "theranostics" as pertaining to immunotherapy, i.e., using molecular diagnostics to identify patients that would most likely benefit from a therapy Presents the new paradigm of biomarker guided R&D and clinical development in immunotherapy of cancer Reviews bottlenecks in translational process of immunotherapies and offers strategies to resolve them

Cancer Vaccines

Cancer Vaccines Book
Author : Ralph M. Steinman,Kenichiro Hasumi,Olivera J. Finn,Jacques Banchereau
Publisher : John Wiley & Sons
Release : 2009-10-19
ISBN : 1573317594
Language : En, Es, Fr & De

GET BOOK

Book Description :

With ten million persons afflicted each year, no one is entirely immune to cancer and its devastating effects on individuals and families. But recent advances in the development of cancer vaccines—either as therapeutic agents or as preventative measures—are hopeful indicators of progress in this field. This volume comprises invited chapters from world-renowned researchers and clinicians that shed light on recent steps forward in immunotherapeutic and preventive approaches for future cancer vaccines. NOTE: Annals volumes are available for sale as individual books or as a journal. For information on institutional journal subscriptions, please visit www.blackwellpublishing.com/nyas. ACADEMY MEMBERS: Please contact the New York Academy of Sciences directly to place your order (www.nyas.org). Members of the New York Academy of Science receive full-text access to the Annals online and discounts on print volumes. Please visit http://www.nyas.org/MemberCenter/Join.aspx for more information about becoming a member.

Building a Cancer Vaccine for Immunotherapy Through Transdifferentiation of Cancer Cells Into Macrophage like Cells

Building a Cancer Vaccine for Immunotherapy Through Transdifferentiation of Cancer Cells Into Macrophage like Cells Book
Author : Calvin Kaing Lee
Publisher :
Release : 2018
ISBN :
Language : En, Es, Fr & De

GET BOOK

Book Description :

Therapeutic cancer vaccination strategies aim to stimulate patient's immune system to combat disease. Approaches to generating cancer vaccines include utilizing autologous tumor cells and tumor-antigen loaded autologous dendritic cells. Recent studies demonstrate the potential to directly convert somatic cells of one lineage into others, a process called transdifferentiation. Here, we show the potential of utilizing this transdifferentiation process to convert cancer cell lines into myeloid-like cells by ectopic expression of two transcription factors, PU.1 and C/EBP[alpha]. The ectopic expression of these two transcription factors induce the expression of surface proteins characteristic of myeloid cells and these transdifferentiated cells acquired the potential to mount a partial inflammatory response to proinflammatory stimuli. Moreover, these transdifferentiated cancer cells generally lose their ability to form tumors in immune competent mice but fail to control parental cell line tumor growth. Mice that developed tumors from the transdifferentiated cells were able to control the progression of parental cell lines better than those that had rejected the transdifferentiated cells. These findings highlight the potential of directly converting cancer cells into antigen-presenting cells as a potential therapeutic vaccination strategy for cancer.

Cancer Immunotherapy Mechanisms of Cancer Immunity Engineering Immune Based Therapies and Developing Clinical Trials

Cancer Immunotherapy  Mechanisms of Cancer Immunity  Engineering Immune  Based Therapies and Developing Clinical Trials Book
Author : Jianxun Song
Publisher : Bentham Science Publishers
Release : 2015-04-16
ISBN : 1681080486
Language : En, Es, Fr & De

GET BOOK

Book Description :

Clinicians, patients and scientists, alike, have been battling cancer for over several decades; however, patient outcomes have not significantly improved over the years with conventional therapies. In recent years, this has caused researchers to look for a change in the status quo, and, the awareness of the human immune system, which has an intrinsic mechanism to control microbial pathogens and dysfunctional self-tissues, has triggered scientists to look for new modes of cancer therapy. Cancer Immunotherapy has become a major research field as a result of these efforts, gaining some recognition for notable breakthroughs in cancer patient prognosis. Frontiers in Cancer Immunology collectively presents the methods which have been studied and used in cancer immunotherapy based on the different components of human immune system. The series will give clinicians and immunologists a roadmap of current trends in all branches of cancer immunology. This volume lists the major immune system components (such as T cells and NK cells and associated antigens/antibodies) which have been demonstrated to limit the growth of or kill tumor cells. Relevant applications in cancer therapy are also included in addition to a general introduction to engineered as well as targeted cancer immunotherapies (cancer vaccines).